Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPY2R | P49146 | 8/20 | 0.74 |
| ▸ | NPY4R | P50391 | 8/20 | 0.74 |
| ▸ | NPY5R | Q15761 | 8/20 | 0.74 |
| ▸ | NPY1R | P25929 | 6/20 | 0.74 |
| ▸ | GLP1R | P43220 | 8/20 | 0.69 |
| ▸ | C5AR1 | P21730 | 1/20 | 0.68 |
| ▸ | CCKBR | P32239 | 2/20 | 0.67 |
| ▸ | GCGR | P47871 | 3/20 | 0.65 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.64 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31000945 | 0.94 | C5AR1 (0.73) | NPY2RNPY4RNPY5RNPY1RGLP1R | |
| SCHEMBL30658235 | 0.93 | NPY2R (0.73) | NPY2RNPY4RNPY5RNPY1RGLP1R | |
| SCHEMBL30658239 | 0.93 | NPY1R (0.69) | NPY2RNPY4RNPY5RNPY1RGLP1R | |
| SCHEMBL31402805 | 0.92 | NPY2R (0.71) | NPY2RNPY4RNPY5RNPY1RGLP1R | |
| SCHEMBL31000951 | 0.92 | C5AR1 (0.71) | NPY2RNPY4RNPY5RNPY1RGLP1R | |
| SCHEMBL29429583 | 0.92 | NPY1R (0.74) | NPY2RNPY4RNPY5RNPY1RGLP1R | |
| SCHEMBL30403572 | 0.92 | GLP1R (0.73) | NPY2RNPY4RNPY5RNPY1RGLP1R | |
| SCHEMBL29429581 | 0.92 | NPY1R (0.74) | NPY2RNPY4RNPY5RNPY1RGLP1R | |
| SCHEMBL30658340 | 0.92 | NPY2R (0.74) | NPY2RNPY4RNPY5RNPY1RGLP1R | |
| SCHEMBL31182646 | 0.92 | NPY2R (0.74) | NPY2RNPY4RNPY5RNPY1RGLP1R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11753627-B2 | Dengue tetravalent vaccine containing a common 30 nucleotide deletion in the 3′-UTR of dengue types 1,2,3, and 4, or antigenic chimeric dengue viruses 1,2,3, and 4 | THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 2023-09-12 | — | — | US | disclosed |